Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HMGA2 antisense RNA 1 (HMGA2-AS1)
- Target
- HMGA2-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript
01
Overview
HMGA2 antisense RNA 1 (HMGA2-AS1) is a natural antisense long non-coding RNA gene located at the HMGA2 locus. It is expressed in multiple cancer cell lines, where its expression correlates with HMGA2 levels. HMGA2-AS1 positively regulates HMGA2, influencing cell migration and tumorigenesis via HMGA2-dependent mechanisms. High HMGA2-AS1 expression is linked to poor prognosis and aggressive cancer phenotypes, particularly in pancreatic cancer. The transcript is subdivided into several variants, with specific roles in gene regulation and cell motility. HMGA2-AS1 represents a novel layer of post-transcriptional regulation and a promising target for future therapeutic approaches in cancer[1][3].
- Other names
- RP11-366L20.2HMGA2-AS1LOC100129940
02
Mechanism of action
(For potential agents) Inhibition or silencing of HMGA2-AS1 (e.g., via siRNA), leading to reduced HMGA2 expression and decreased cell migration/proliferation
03
Biological functions
Regulation of gene expression (specifically HMGA2)Modulation of cell migration and motilityPromotion of tumorigenesis (via HMGA2-dependent mechanisms)Involvement in mesenchymal stem cell differentiation and adipogenesis
04
Disease associations
Cancer (pancreatic cancer, prostate cancer, breast, colon, liver, thyroid cancer, based on expression studies)Potential role in metastatic progression
05
Biomarkers
High HMGA2-AS1 expression is associated with poor prognosis in pancreatic cancerHMGA2-AS1 levels may serve as a biomarker for tumor aggressiveness or metastatic potential
Beyond the preview
Go deeper on HMGA2 antisense RNA 1 (HMGA2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HMGA2 antisense RNA 1 (HMGA2-AS1).